Hormonal
High-volume static stretching improves glycemic control (post-prandial glucose and HbA1c) in individuals with Type 2 Diabetes, potentially by increasing GLUT-4 translocation via AMPK and CaMK pathways.
If you have Type 2 Diabetes, incorporating static stretching into your routine may help lower blood sugar levels, especially after meals. It works by helping your muscles take up glucose without needing as much insulin. It is not a replacement for medication but a helpful addition.
Stretching exercise, performed actively or passively, might increase the amount of circulating and cell-surface-docking intramuscular insulin-independent glucose transporter type 4 (GLUT-4)... Stretching exercise may be assumed to have a longer and more intense duration of action on cellular glucose uptake than most of the exogenously applied bolus insulins
Why this rating
Based on a meta-analysis cited in the review; the paper itself is an opinion.
Source
Implications and Applications of Stretch-Mediated Hypertrophy in Therapy, Rehabilitation and Athletic Training—An Outlook to Future Potential Applications
Konstantin Warneke et al. · Sports Medicine · 2025
DOI 10.1007/s40279-025-02237-y
More from this paper
- High-volume static stretching (≥15 minutes per muscle group, >3 times per week) induces muscle hypertrophy and strength increases comparable to resistance training, primarily by generating high-magnitude mechanical tension that activates mTOR/p70S6K signaling pathways.Moderate
- High-volume static stretching is a viable therapeutic alternative or supplement for counteracting immobilization-induced muscle atrophy in patients who are bedridden, post-surgery, or have mobility restrictions.Limited
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →